NCT00641329View on ClinicalTrials.gov

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
ADHD
Interventions
DRUG

CLONICEL (clonidine HCl sustained release)

Flexible Dose (0.1 - 0.4 mg)

DRUG

Placebo

Matching placebo tablets

Trial Locations (23)

21208

Baltimore

27514

Chapel Hill

27705

Durham

33161

Miami

33319

Lauderhill

34208

Bradenton

40004

Bardstown

44106

Cleveland

63005

St Louis

72205

Little Rock

73103

Oklahoma City

73116

Oklahoma City

77007

Houston

77074

Houston

77488

Wharton

77566

Lake Jackson

84015

Clinton

92103

San Diego

92243

El Centro

92612

Irvine

98033

Kirkland

99202

Spokane

08021

Clementon

Sponsors
All Listed Sponsors
lead

Addrenex Pharmaceuticals, Inc.

INDUSTRY

NCT00641329 - CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD | Biotech Hunter | Biotech Hunter